240 related articles for article (PubMed ID: 18414107)
81. Bimatoprost/timolol: a review of its use in glaucoma and ocular hypertension.
Curran MP; Orman JS
Drugs Aging; 2009; 26(2):169-84. PubMed ID: 19220073
[TBL] [Abstract][Full Text] [Related]
82. Comparison of intraocular pressure-lowering effect of every night versus every other night dosing of bimatoprost 0.03%.
Shazly TA; Latina MA
J Ocul Pharmacol Ther; 2011 Aug; 27(4):369-71. PubMed ID: 21663517
[TBL] [Abstract][Full Text] [Related]
83. A 12-week study evaluating the efficacy of bimatoprost 0.03% in patients with pseudoexfoliative and open-angle glaucoma.
Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Toto L; Mastropasqua L
Eur J Ophthalmol; 2009; 19(4):594-600. PubMed ID: 19551674
[TBL] [Abstract][Full Text] [Related]
84. Real-life experience study of the safety and efficacy of travoprost 0.004% / timoptol 0.50% fixed combination ophthalmic solution in intraocular pressure control.
Olali C; Malietzis G; Ahmed S; Samaila E; Gupta M
Niger J Clin Pract; 2011; 14(1):29-33. PubMed ID: 21493988
[TBL] [Abstract][Full Text] [Related]
85. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
[TBL] [Abstract][Full Text] [Related]
86. Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension.
Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Araie M;
Am J Ophthalmol; 2013 Oct; 156(4):731-6. PubMed ID: 23831221
[TBL] [Abstract][Full Text] [Related]
87. Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network.
Loftus J; Christopoulou D; Blak BT; Hards M
Eur J Ophthalmol; 2012; 22(3):376-87. PubMed ID: 22034021
[TBL] [Abstract][Full Text] [Related]
88. Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1).
Medeiros FA; Walters TR; Kolko M; Coote M; Bejanian M; Goodkin ML; Guo Q; Zhang J; Robinson MR; Weinreb RN;
Ophthalmology; 2020 Dec; 127(12):1627-1641. PubMed ID: 32544560
[TBL] [Abstract][Full Text] [Related]
89. Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Serle JB; Katz LJ; McLaurin E; Heah T; Ramirez-Davis N; Usner DW; Novack GD; Kopczynski CC;
Am J Ophthalmol; 2018 Feb; 186():116-127. PubMed ID: 29199013
[TBL] [Abstract][Full Text] [Related]
90. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension.
Higginbotham EJ; Schuman JS; Goldberg I; Gross RL; VanDenburgh AM; Chen K; Whitcup SM;
Arch Ophthalmol; 2002 Oct; 120(10):1286-93. PubMed ID: 12365906
[TBL] [Abstract][Full Text] [Related]
91. Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study.
Khouri AS; Serle JB; Bacharach J; Usner DW; Lewis RA; Braswell P; Kopczynski CC; Heah T;
Am J Ophthalmol; 2019 Aug; 204():97-104. PubMed ID: 30862500
[TBL] [Abstract][Full Text] [Related]
92. Relative efficacy of prostaglandins.
Laxmana Rao HB; Sekhar GC
Ophthalmology; 2009 Jul; 116(7):1418; author reply 1418-9. PubMed ID: 19576507
[No Abstract] [Full Text] [Related]
93. A randomized clinical trial comparing three fixed combinations of bimatoprost with timolol in patients with open-angle glaucoma or ocular hypertension.
Mrukwa-Kominek E; Misiuk-Hojlo M; Csutak A; Stalmans I; Garhofer G
Curr Med Res Opin; 2023 May; 39(5):775-783. PubMed ID: 37013445
[TBL] [Abstract][Full Text] [Related]
94. [Evaluation of the effect of bimatoprost/timolol fixed combination on ocular blood flow in patients with ocular hypertension using colour Doppler imaging. Preliminary study].
García-Pérez JL; Puerto-Hernández B; Rebolleda Fernández G; Muñoz-Negrete FJ; González-Gordaliza C
Arch Soc Esp Oftalmol; 2010 Apr; 85(4):131-7. PubMed ID: 20858400
[TBL] [Abstract][Full Text] [Related]
95. Comparison of tropical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J. Glaucoma 2001;10:414-22.
Goldberg I
J Glaucoma; 2002 Jun; 11(3):275. PubMed ID: 12140407
[No Abstract] [Full Text] [Related]
96. Corneal thickness and glaucoma medications.
Mehdizadeh M; Jamshidian-Tehrani M; Nowroozzadeh MH
Ophthalmology; 2009 Jul; 116(7):1416-7; author reply 1417, 1417.e1. PubMed ID: 19576505
[No Abstract] [Full Text] [Related]
97. Ocular hypotensive effect of oral palmitoyl-ethanolamide: a clinical trial.
Gagliano C; Ortisi E; Pulvirenti L; Reibaldi M; Scollo D; Amato R; Avitabile T; Longo A
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6096-100. PubMed ID: 21705689
[TBL] [Abstract][Full Text] [Related]
98. Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.
Wang K; Xu L; Yuan Z; Yao K; Zhao J; Xu L; Fang A; Zhang M; Wu L; Ji J; Hou J; Liu Q; Sun X
BMC Ophthalmol; 2014 Feb; 14():21. PubMed ID: 24568617
[TBL] [Abstract][Full Text] [Related]
99. A comparison of 0.1% timolol eye gel and 0.5% timolol eye drop in patients with chronic angle-closure glaucoma.
Metheetrairut A; Leumsamran P; Rojananin S; Kitnarong N
J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S116-22. PubMed ID: 22696863
[TBL] [Abstract][Full Text] [Related]
100. Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: a preliminary study.
Vyas P; Naik U; Gangaiah JB
Indian J Ophthalmol; 2011; 59(1):13-6. PubMed ID: 21157066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
